Focuses on neuroimmune mechanisms of CNS injury and repair. Through in vitro and in vivo models, the work reprograms innate immune responses—phagocytosis, cytokine signaling, and metabolism—to resolve inflammation and promote regeneration in spinal cord injury and stroke.